Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Influx HealthtechNSE:INFLUX -0.29%21 Days Inventory is 49.31 as of Mar. 2026, which is 162% above its 10-year median of 18.82. GuruFocus rates NSE:INFLUX with a GF Score™ of 21/100. The stock has 4 warning signs investors should review. Among 922 Drug Manufacturers companies, Influx Healthtech ranks better than 92.84% on this metric.
The historical rank and industry rank for Influx Healthtech's Days Inventory or its related term are showing as below:
NSE:INFLUX'
s Days Inventory Range Over the Past 10 Years
Min: 11.76 Med: 18.82 Max: 61.37
Current: 55.83
During the past 5 years, Influx Healthtech's highest Days Inventory was 61.37. The lowest was 11.76. And the median was 18.82.
NSE:INFLUX's Days Inventory is ranked better than 92.84% of 922
companies
in the Drug Manufacturers industry
Industry Median: 164.58
vs NSE:INFLUX: 55.83
Influx Healthtech's Days Inventory
declined
from Mar. 2025 (57.30) to Mar. 2026 (49.31).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Influx Healthtech's Inventory Turnover for the
six
months ended in Mar. 2026 was 3.70.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Influx Healthtech's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.17.
Influx Healthtech (NSE:INFLUX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Influx Healthtech's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Influx Healthtech's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Influx Healthtech Days Inventory Related Terms
Influx Healthtech Days Inventory Historical Data
* Premium members only.
The historical data trend for Influx Healthtech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Influx Healthtech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Influx Healthtech Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Influx Healthtech's Days Inventory distribution charts can be found below:
* The bar in red indicates where Influx Healthtech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Influx Healthtech (NSE:INFLUX) has a Days Inventory of 49.31 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Influx Healthtech and its competitors. This is 162% above median its historical median of 18.82. Over the past decade, Influx Healthtech's Days Inventory has ranged from 11.76 to 61.37. According to the industry distribution chart, Influx Healthtech ranks #66 out of 922 companies in the Drug Manufacturers industry, placing it in the top 7.2%.
Is Influx Healthtech's Days Inventory too high?
Influx Healthtech's current Days Inventory of 49.31 is 162% above median its 10-year median of 18.82. Over the past 10 years, this metric has ranged from a low of 11.76 to a high of 61.37. The Drug Manufacturers industry median Days Inventory is 164.58. Influx Healthtech's value of 49.31 is 70% below this industry median. Based on the distribution chart, Influx Healthtech ranks #66 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Influx Healthtech has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Influx Healthtech's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Influx Healthtech ranks #66 out of 922 companies for Days Inventory. This places Influx Healthtech in the top 7% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.58. Influx Healthtech's value of 49.31 is 70% below this benchmark. Historically, Influx Healthtech's own Days Inventory has ranged from 11.76 to 61.37 over the past decade. While the company's 10-year median is 18.82 vs. the industry median of 164.58, Influx Healthtech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.58, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Influx Healthtech's current Days Inventory of 49.31 is 70% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Influx Healthtech and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Influx Healthtech's current Days Inventory is 49.31, which is 162% above median its own 10-year median of 18.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Influx Healthtech stock overvalued right now?
Influx Healthtech (NSE:INFLUX) has a current Days Inventory of 49.31. The current Days Inventory is 49.31, which is 162% above median its 10-year median of 18.82 and 70% below the Drug Manufacturers industry median of 164.58. Influx Healthtech's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Influx Healthtech (NSE:INFLUX), the current Days Inventory is 49.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Influx Healthtech Ltd is a Mumbai-based, healthcare-focused company specialising in contract manufacturing. The company operates manufacturing facilities located in Thane. Its expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables. The company generates the majority of its revenue from sale of products.
21GF Score
Get the complete analysis for NSE:INFLUX
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INFLUX has been successfully added to your 
